Dose response relationship between duration of statin use and incidence of herpes zoster.

Dose response relationship between duration of statin use and incidence of herpes zoster.</p

Baseline clinical characteristics of the study patients.^a

Baseline clinical characteristics of the study patients.a</p

Flow diagram of the study.

Flow diagram giving details of the enrolled individuals, and the procedure for propensity score matching.</p

Cumulative incidences of herpes zoster (%) according to the use of statins.

<p>Kaplan–Meier curves showing cumulative incidences (%) of individuals suffering from herpes zoster. Red line indicating herpes zoster in statin users. Blue line depicting herpes zoster in non-statin users. The difference between statin users and non-statin users was significant (<i>p</i> < .0001 by the log rank test).</p

Baseline clinical characteristics of the cohort.

<p>Baseline clinical characteristics of the cohort.</p

Risks of herpes zoster in statin users and non-statin users.

<p>Risks of herpes zoster in statin users and non-statin users.</p

Univariate and multivariate analysis of factors for clinical failure and 30-day mortality.

<p>Univariate and multivariate analysis of factors for clinical failure and 30-day mortality.</p

Clinical outcomes of the study patients.^a

<p>Clinical outcomes of the study patients.<a href="http://www.plosone.org/article/info:doi/10.1371/journal.pone.0150642#t002fn002" target="_blank">^a</a></p

Disposition of MDR/XDRAB pneumonia patients included in the analysis of the impact of tigecycline-based versus colistin-based therapy.

<p>MDR/XDRAB, multidrug-resistant and extensively drug-resistant <i>Acinetobacter baumannii</i>; TGC, tigecycline; CST, colistin; SUL, sulbactam; MIN, minocycline; RFP, rifampicin; DOX, doxycycline; ^a for patients with multiple episodes of MDR/XDRAB pneumonia, the first episode was included in the analysis.</p

Clinical outcomes of monotherapy versus combination therapy.^a

<p>Clinical outcomes of monotherapy versus combination therapy.<a href="http://www.plosone.org/article/info:doi/10.1371/journal.pone.0150642#t003fn002" target="_blank">^a</a></p